Resources

May 7, 2021
A new IQVIA report found that biosimilar adoption is more favorable where relative reimbursement to physicians is higher for the biosimilar.
Doctor meets with diabetic senior woman at medical appointment
April 23, 2021
The Biosimilars Council strongly supports the reintroduction, and encourages swift passage, of the bipartisan BIOSIM Act (HR 2815).
April 20, 2021
Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.
March 25, 2021
Physicians and hospitals play a critical role in biosimilar adoption. This paper highlights the importance of examining ways to remove obstacles that may discourage providers from utilizing lower-cost biosimilars with their patients.
February 22, 2021
This paper examines the challenges to market sustainability for generic and biosimilar medicines that have cleared the regulatory and patent hurdles to obtain FDA approval and launch into the U.S. market.
biosimilars news january 2021
February 9, 2021
January's newsletter with the latest updates in the biosimilars industry including policy movement, educational resources and upcoming events.

Recent Tweets